Features

Latest Features

Investigating the Link Between Atrial Fibrillation and Type 2 Diabetes

Investigating the Link Between Atrial Fibrillation and Type 2 Diabetes

Compared with the general population, patients with type 2 diabetes are at a 35% to 60% greater risk for atrial fibrillation.

Bipolar Disorder and the Cardiovascular System

Bipolar Disorder and the Cardiovascular System

Screening for cardiovascular disease risk is recommended for clinicians who manage patients with bipolar disorder.

Risk Factors for Atherosclerotic Cardiovascular Disease in the South Asian Population

Risk Factors for Atherosclerotic Cardiovascular Disease in the South Asian Population

South Asians exhibit the highest rates of ASCVD among all ethnic groups, and the highest prevalence is in younger age groups; up to 25% of myocardial infarctions in India occur in individuals younger than 40 years of age.

PCSK9 Inhibition: Benefits Outweigh Risks in Patients With Diabetes

PCSK9 Inhibition: Benefits Outweigh Risks in Patients With Diabetes

Statin therapy is the first line of defense against high LDL-C and the risk for atherosclerotic cardiovascular disease, the leading cause of morbidity and mortality in individuals with diabetes.

ASPREE Trial: Aspirin Associated With Higher Mortality, Hemorrhage Risk in Older Adults

ASPREE Trial: Aspirin Associated With Higher Mortality, Hemorrhage Risk in Older Adults

The use of aspirin in healthy elderly patients as a preventative strategy was associated with no prolongation of long-term disability-free survival compared with placebo.

Enrolling the Uninsured in Clinical Trials: Is it Ethical?

Enrolling the Uninsured in Clinical Trials: Is it Ethical?

Until universal access to healthcare is ensured as a human right, researchers must keep important ethical concerns in mind when designing future clinical trials.

Doctors and the D Word: Talking About Death Is an Essential Skill — and One Often Lacking

Doctors and the D Word: Talking About Death Is an Essential Skill — and One Often Lacking

The reasons for physicians' discomfort with conversations about dying are as much cultural, social, and systemic as they are personal.

Assessing the Evidence of Aspirin for Primary Prevention in Diabetes

Assessing the Evidence of Aspirin for Primary Prevention in Diabetes

The substantial burden of cardiovascular disease in patients with diabetes has led to the exploration of various cardiovascular disease prevention strategies, including the use of aspirin.

Nutraceuticals May Benefit Patients Who Are Statin Intolerant

Nutraceuticals May Benefit Patients Who Are Statin Intolerant

Nutraceuticals may offer a solution to patients who cannot tolerate statins because of severe muscle pain.

The Uncertain Association Between Abacavir and the Risk for Acute Myocardial Infarction

The Uncertain Association Between Abacavir and the Risk for Acute Myocardial Infarction

A higher prevalence of traditional cardiovascular risk factors may be partially responsible for the increased incidence of cardiovascular disease in people living with HIV.

Supplementing Pulmonary Arterial Hypertension Therapy With Nutritional Changes

Supplementing Pulmonary Arterial Hypertension Therapy With Nutritional Changes

Current research suggests patients with pulmonary arterial hypertension may benefit from iron and vitamin D supplementation.

Hypertension Disorders in Pregnancy: The Potential of Prophylactic Aspirin

Hypertension Disorders in Pregnancy: The Potential of Prophylactic Aspirin

To aid in the prevention of preeclampsia, American College of Obstetricians and Gynecologists and the US Preventive Services Task Force recommend low-dose aspirin prophylaxis in patients with 1 or more high-risk factors.

Unraveling the Relationship Between COPD and Stroke

Unraveling the Relationship Between COPD and Stroke

Although COPD has been identified as a risk factor for cardiovascular disease, researchers are less certain about the relationship between COPD and stroke.

Managing Cardiovascular Risk in Rheumatoid Cachexia

Managing Cardiovascular Risk in Rheumatoid Cachexia

Because of the increased risk for cardiovascular disease in patients with rheumatoid arthritis, the increase in fat mass caused by rheumatoid cachexia can be especially concerning.

Improving Risk Stratification, Diagnostic Accuracy in PAH With Cardiopulmonary Exercise Testing

Improving Risk Stratification, Diagnostic Accuracy in PAH With Cardiopulmonary Exercise Testing

Cardiopulmonary exercise testing can be an important diagnostic and prognostic tool in pulmonary arterial hypertension.

Should Physicians Treat Family and Friends? Three Experts Weigh In

Should Physicians Treat Family and Friends? Three Experts Weigh In

Although all of the guidelines acknowledge that there are emergent situations in which providing care for a family member or friend is not only permissible but also essential, other situations are frowned upon.

Clinician Perspective: Examining the Link Between Antipsychotics and Diabetes

Clinician Perspective: Examining the Link Between Antipsychotics and Diabetes

Endocrinologist Kevin M. Pantalone, DO, and psychiatrist Christian Kohler, MD, discuss the risk associated with the use of antipsychotic medications in individuals with type 2 diabetes.

How Many Chances Are Too Many? Treating Recurrent Infective Endocarditis in IV Drug Users

How Many Chances Are Too Many? Treating Recurrent Infective Endocarditis in IV Drug Users

How many second chances should a drug user get? As many as it takes for us — physicians, society, government, and the healthcare system — to get it right.

Connective Tissue Diseases in Comorbid PAH: A Case for Separating SSc, SLE

Connective Tissue Diseases in Comorbid PAH: A Case for Separating SSc, SLE

Recent evidence suggests that systemic sclerosis and systemic lupus erythematosus comorbid with pulmonary arterial hypertension should be considered separate diseases.

Improved Pulmonary Arterial Hypertension Risk Prediction Tools Needed

Improved Pulmonary Arterial Hypertension Risk Prediction Tools Needed

The use of a risk calculator aimed at achieving a low-risk profile in PAH trials is discussed.

Sign Up for Free e-Newsletters